Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Meng

Showing results (221-230 of 711) with videos related to

Pageof 72
Sort By:
Radiology|March 1, 1974
Arteriography of unusual mass lesions of the mesenteryA B Diamond, C H Meng, R R Goldin
Clinical Biochemistry|July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension XpandQing H Meng, Beverly C Handy, Elizabeth A Wagar
Biomedical and Environmental Sciences : BES|December 1, 1994
Production and characterization of sterigmatocystinJ L Lou, Z H Meng, D S Wang
Pediatrics|January 1, 1973
Selective intra-arterial vasopressin in the management of stress ulcers in childhoodA G Lerner, C H Meng, K M Schneider
Regulatory Peptides|December 15, 1994
Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressinH Meng, D Wielbo, R Gyurko, et al.
Neuroscience|June 25, 1998
Rat striatal adenosinergic modulation of ethanol-induced motor impairment: possible role of striatal cyclic AMPZ H Meng, S N Pennington, M S Dar
Nucleic Acids Research|June 11, 1992
Two distinct pathways of interferon induction as revealed by 2-aminopurineL Daigneault, A Haggarty, Q H Meng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2008
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blockerShiming Zhu, Yuying Liu, Liqi Wang, et al.
European Journal of Pharmacology|January 14, 2000
Intravenous AMP 579, a novel adenosine A(1)/A(2a) receptor agonist, induces a delayed protection against myocardial infarction in minipigH Meng, M McVey, M Perrone, et al.
Inflammation & Allergy Drug Targets|May 5, 2011
Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?M S Ahmed, Jing Zhang Ji, Qing H Meng
Pageof 72

Showing results (221-230 of 711) with videos related to

Sort By:
Pageof 72
Radiology|March 1, 1974
Arteriography of unusual mass lesions of the mesenteryA B Diamond, C H Meng, R R Goldin
Clinical Biochemistry|July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension XpandQing H Meng, Beverly C Handy, Elizabeth A Wagar
Biomedical and Environmental Sciences : BES|December 1, 1994
Production and characterization of sterigmatocystinJ L Lou, Z H Meng, D S Wang
Pediatrics|January 1, 1973
Selective intra-arterial vasopressin in the management of stress ulcers in childhoodA G Lerner, C H Meng, K M Schneider
Regulatory Peptides|December 15, 1994
Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressinH Meng, D Wielbo, R Gyurko, et al.
Neuroscience|June 25, 1998
Rat striatal adenosinergic modulation of ethanol-induced motor impairment: possible role of striatal cyclic AMPZ H Meng, S N Pennington, M S Dar
Nucleic Acids Research|June 11, 1992
Two distinct pathways of interferon induction as revealed by 2-aminopurineL Daigneault, A Haggarty, Q H Meng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2008
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blockerShiming Zhu, Yuying Liu, Liqi Wang, et al.
European Journal of Pharmacology|January 14, 2000
Intravenous AMP 579, a novel adenosine A(1)/A(2a) receptor agonist, induces a delayed protection against myocardial infarction in minipigH Meng, M McVey, M Perrone, et al.
Inflammation & Allergy Drug Targets|May 5, 2011
Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?M S Ahmed, Jing Zhang Ji, Qing H Meng
Pageof 72